Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries

Retina

Volumn 33, Issue 5, 2013, Pages 911-919

  Hahn, Paul ^a   Acquah, Kofi ^b   Cousins, Scott W ^a   Lee, Paul P ^c   Sloan, Frank A ^d  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; RETINA MACULA AGE RELATED DEGENERATION; UNITED STATES;

AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MACULAR DEGENERATION; MALE; MEDICARE; RISK FACTORS; UNITED STATES;

EID: 84876970777     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182831248     Document Type: Article

References (34)

1. Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol 2000;118: 819-825.
2. Weih LM, VanNewkirk MR, McCarty CA, Taylor HR. Agespecific causes of bilateral visual impairment. Arch Ophthalmol 2000;118:264-269.
3. Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care 2004;27(suppl 1):S84- S87.
4. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-572.
5. Klein R, Klein BE, Moss SE. Diabetes, hyperglycemia, and age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:1527-1534.
6. Mitchell P, Wang JJ. Diabetes, fasting blood glucose and agerelated maculopathy: The Blue Mountains Eye Study. Aust N Z J Ophthalmol 1999;27:197-199.
7. Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 2005;112:533-539.
8. Leske MC, Wu SY, Hennis A, et al. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology 2006;113:29-35.
9. Topouzis F, Anastasopoulos E, Augood C, et al. Association of diabetes with age-related macular degeneration in the EUREYE study. Br J Ophthalmol 2009;93:1037-1041.
10. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 1973;90:206-217.
11. Benson WE, Brown GC, Tasman W. Diabetes and Its Ocular Complications. Philadelphia, PA: Saunders; 1988.
12. Borrone R, Saravia M, Bar D. Age related maculopathy and diabetes. Eur J Ophthalmol 2008;18:949-954.
13. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977;106:33-41.
14. Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: A case-control study. Ann Ophthalmol 1979;11:1197-1201.
15. Hyman LG, Lilienfeld AM, Ferris FL III, Fine SL. Senile macular degeneration: A case-control study. Am J Epidemiol 1983;118:213-227.
16. Blumenkranz MS, Russell SR, Robey MG, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93:552-558.
17. Voutilainen-Kaunisto RM, Terasvirta ME, Uusitupa MI, Niskanen LK. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: A 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care 2000;23:1672-1678.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40: 373-383.
19. Parsons LS. Performing a 1:N Case-Control Match on Propensity Score. Available at: http://www2.sas.com/proceedings/sugi29/165-29.pdf. Accessed April 9, 2012.
20. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 2007;26:734-753.
21. Zylbermann R, Landau D, Rozenman Y, et al. Exudative agerelated macular degeneration in patients with diabetic retinopathy and its relation to retinal laser photocoagulation. Eye (Lond) 1997;11(pt 6):872-875.
22. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-532.
23. Wong J, Molyneaux L, Constantino M, et al. Timing is everything: Age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care 2008;31:1985-1990.
24. Bethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med 2007;167:921-927.
25. Sloan FA, Bethel MA, Ruiz D Jr, et al. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med 2008;168:192-199; discussion 199.
26. Vidaurri JS, Pe'er J, Halfon ST, et al. Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica 1984;188:243-247.
27. Algvere P, Efendic S, Luft R, Wajngot A. Retinal microangiopathy and pigment epithelial lesions in subjects with normal, borderline, and decreased oral glucose tolerance. Br J Ophthalmol 1985;69:416-419.
28. Jensen VA, Lundbaek K. Diabetic pigmentopathy of the mascula lutea; a new ophthalmological anomaly in long-term diabetes. Ophthalmologica 1955;129:89-93.
29. Howes KA, Liu Y, Dunaief JL, et al. Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci 2004;45:3713-3720.
30. Stitt AW. AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 2010;51:4867-4874.
31. Chiu CJ, Milton RC, Gensler G, Taylor A. Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am J Clin Nutr 2007;86:180-188.
32. Zhang X, Gregg EW, Cheng YJ, et al. Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004. Arch Ophthalmol 2008;126:1421-1427.
33. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36: 331-335.
34. Curtis LH, Hammill BG, Schulman KA, Cousins SW. Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 2010;128:1273-1279.